Federal Register / Vol. 65, No. 126 / Thursday, June 29, 2000 / Notices 40099

Dated: June 23, 2000.

Nancy Cheal,

Acting Associate Director for Policy, Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–16436 Filed 6–28–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement Number 00064]

Notice of Availability of Funds;

Announcement of a Cooperative

Agreement With the Minority Health

Professions Foundation To Enhance

Professional Education, Research

Infrastructure, and Community Service

in the Areas of Health Promotion and

Disease Prevention Partnering With

African American Institutions

A. Purpose

The Centers for Disease Control and

Prevention (CDC) and the Agency for

Toxic Substances and Disease Registry

(ATSDR) announce the availability of

fiscal year (FY) 2000 funds for a

cooperative agreement program with the

Minority Health Professions Foundation

(MHPF). The purpose of the program is

to assist the Minority Health Professions

Foundation in the following manner:

1. To improve the practice of public

health at member schools by

strengthening their public health

infrastructure;

2. To enhance the quantitative and

qualitative analytic research

infrastructure of the participating

institutions;

3. To strengthen the educational and

professional development of minority

health professionals and educators;

4. To support student training

initiatives, in order to introduce public

health to minority students;

5. To provide health education and

outreach for decreasing the needs of the

poor, minority, and under-served

populations; and

6. To enhance the interactions

between the Minority Health

Professions Foundation schools, the

historically black colleges and

universities and public health

institutions.

This program addresses the

commitments of the CDC and ATSDR in

achieving the health promotion and

disease prevention objectives of

‘‘Healthy People 2010’’, a national

activity to reduce morbidity and

mortality, while improving the quality

of life. This announcement is related to

the 2010 objectives, which specify

improving the health of groups of

people bearing a disproportionate

burden of poor health, as compared to

the total population. The framework of

‘‘Healthy People 2010’’ consists of two

broad goals which are to:

1. Increase quality and years of

healthy life; and

2. Eliminate health disparities.

The goals of ‘‘Healthy People 2010’’

have been established as the Nation’s

prevention goals and as a scorecard for

monitoring health status. The nations

goals and objectives established in

‘‘Healthy People 2010’’ will build upon

the foundation for establishing a small

set of leading health indicators that

could be presented to the general public

and non-health professionals as an

introduction to ‘‘Healthy People’’.

‘‘Healthy People 2010’’ will be a tool for

monitoring America’s health. For the

conference copy of ‘‘Health People

2010’’ visit the internet site: <http://

www.health.gov/healthypeople>.

Eliminating disparities by the year

2010 will require new knowledge about

the determinants of disease and

effective interventions for prevention

and treatment. It will also require

improved access for all to the resources

that influence health. Reaching this goal

will necessitate improved collection and

use of standardized data to correctly

identify all high-risk populations and

monitor the effectiveness of health

interventions targeting these groups.

Research dedicated to a better

understanding of the relationships

between health status and income,

education, race and ethnicity, cultural

influences, environment, and access to

quality medical services will help us

acquire new insights into eliminating

the disparities and developing new

ways to apply our existing knowledge

toward this goal. Improving access to

quality health care and the delivery of

preventive and treatment services will

require working more closely with

communities to identify culturally

sensitive implementation strategies.

While the nation has made

remarkable progress in understanding

the causes and risks for developing

diseases that have important

implications for the health of all

Americans, the health status of the

nation’s minority and poor lag

considerably behind that of White

Americans. The contributing factors for

many disparities include inadequate

family incomes, lack of access to

medical care, and environmental

hazards. The greatest opportunities for

improvement and the greatest threats to

the future health status of the Nation

reside in the population groups that

have historically been disadvantaged

economically, educationally and

politically. In partnering with different

racial and ethnic groups, the CDC can

work closely with institutions,

organizations, and communities to help

eliminate disparities in health while

meeting the goals of ‘‘Healthy People

2010’’.

B. Eligible Applicants

Assistance will be provided only to

the Minority Health Professions

Foundation (MHPF). No other

applications are solicited.

The MHPF is the most appropriate

and qualified organization to provide

services specified under this

cooperative agreement because:

1. The MHPF is dedicated to

supporting the organizational growth of

minority health professional schools to

ensure the advancement of specific

research in minority health, the

education and professional

development of minority health care

professionals and educators, and the

continuing provision of health services

in minority and poor communities;

2. The MHPF represents twelve

member institutions which include

medical, dental, pharmacy, and

veterinary medicine schools in

historically African-American colleges

and universities. Collectively, these

institutions have trained one out of

every two African American physicians,

dentists, and pharmacists; and three out

of every four African American

veterinarians. The member institutions

have also trained a substantial number

of other minority and non-minority

health professionals;

3. The MHPF member institutions are

comprised of the Historically Black

Colleges and Universities (HBCUs) that

not only house the health professions

schools, but three of which house

schools of public health;

4. The primary objective of the MHPF

and the nine Historically Black Colleges

and Universities is to address the health

needs of African American and other

minority population groups;

5. The MHPF institutional members

have significantly fostered and

advanced dramatic growth and

expansion of its member institution’s

collaborative efforts, bolstered and

supported considerable increase in

public health, medical and scientific

research, and assisted in amplifying

minority health community education

and outreach nationally;

6. The MHPF and its member schools

have the capacity to conduct basic

sciences and clinical research, and are

attacking the various diseases and

conditions that disproportionately

40100 Federal Register / Vol. 65, No. 126 / Thursday, June 29, 2000 / Notices

impact minority and disadvantaged

citizens in America; and

7. The MHPF member institutions

were founded specifically to improve

the health status of medically

underserved African Americans and

other ethnic minority groups, and play

a critical role in building the nation’s

health care workforce.

C. Availability of Funds

Approximately $200,000 is available

in FY 2000 to fund this cooperative

agreement. Sub-awards will be funded

through CDC and ATSDR. A cumulative

award of approximately $2,000,000 to

the MHPF is expected during FY 2000.

Subawards will range from $25,000 to

$450,000. It is expected that the awards

will begin on September 30, 2000.

Funding estimates may vary and are

subject to change. Continuation awards

within the project period will be made

on the basis of satisfactory progress and

the availability of funds.

Applications that exceed the funding

cap of $450,000 will be excluded from

the competition and returned to the

applicant.

D. Where To Obtain Additional

Information

A complete program description and

information on application procedures

are contained in the application

package. Business management

technical assistance may be obtained

from Sheri Disler, Senior Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 2920

Brandywine Road, Room 3000, MS E–

15, Koger Center, Colgate Building,

Atlanta, Georgia 30341–3724.

Telephone 770–488–2756. E-mail

address sjd9@cdc.gov.

Program technical assistance may be

obtained from Karen E. Harris, Senior

Advisor for Research Projects, Office of

the Associate Director for Minority

Health, Office of the Director, Centers

for Disease Control and Prevention,

1600 Clifton Road, Northeast, Mailstop

D–39, Atlanta, Georgia 30333.

Telephone (404) 639–4313, E-mail

address keh2@cdc.gov.

Dated: June 23, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–16437 Filed 6–28–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N–0914]

Agency Information Collection

Activities; Submission for OMB

Review; Comment Request; Importer’s

Entry Notice

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that the proposed collection of

information listed below has been

submitted to the Office of Management

and Budget (OMB) for review and

clearance under the Paperwork

Reduction Act of 1995.

DATES: Submit written comments on the

collection of information by July 31,

2000.

ADDRESSES: Submit written comments

on the collection of information to the

Office of Information and Regulatory

Affairs, OMB, New Executive Office

Bldg., 725 17th St. NW., rm. 10235,

Washington, DC 20503, Attn: Wendy

Taylor, Desk Officer for FDA.

FOR FURTHER INFORMATION CONTACT:

JonnaLynn P. Capezutto, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–4659.

SUPPLEMENTARY INFORMATION: In

compliance with 44 U.S.C. 3507, FDA

has submitted the following proposed

collection of information to OMB for

review and clearance.

Importer’s Entry Notice (OMB Control

Number 0910–0046)—Extension

Section 801 of the Federal Food, Drug,

and Cosmetic Act (the act) (21 U.S.C.

381) charges FDA with the following

responsibilities: (1) Ensuring that

foreign-origin FDA-regulated foods,

drugs, cosmetics, medical devices, and

radiological health products offered for

import into the United States meet the

same requirements of the act as do

domestic products; and (2) preventing

shipments from entering the country if

they are not in compliance.

The information collected by FDA

consists of the following: (1) Product

code, an alpha-numeric series of

characters that identifies each product

FDA regulates; (2) FDA country of

origin, the country where the FDAregistered or FDA-responsible firm is

located; (3) FDA manufacturer, the party

who manufactured, grew, assembled, or

otherwise processed the goods (if more

than one, the last party who

substantially transformed the product);

(4) shipper, the party responsible for

packing, consolidating, or arranging the

shipment of the goods to their final

destination; (5) quantity and value of

the shipment; and (6) if appropriate,

affirmation of compliance, a code that

conveys specific FDA information, such

as registration number, foreign

government certification, etc. This

information is collected electronically

by the entry filer via the U.S. Customs

Service’s Automated Commercial

System at the same time he/she files an

entry for import with the U.S. Customs

Service. FDA uses the information to

make admissibility decisions about

FDA-regulated products offered for

import into the United States.

The annual reporting burden is

derived from the basic processes and

procedures used in fiscal year (FY)

1995. The total number of entries

submitted to the automated system in

FY 1999 was 5,077,493. The total

number of entries less the disclaimer

entries will represent the total FDA

products entered into the automated

system. A total of 51 percent of all

entries entered into the automated

system were entries dealing with FDAregulated products. The number of

respondents is a count of filers who

submit entry data for foreign-origin

FDA-regulated products. The estimated

reporting burden is based on

information obtained by FDA contacting

some potential respondents. Disclaimer

entries are not FDA commodities.

FDA estimates the burden of this

collection of information as follows: